Morphine- and buprenorphine-induced analgesia and antihyperalgesia in a human inflammatory pain model: A double-blind, randomized, placebo-controlled, five-arm crossover study

Journal of Pain Research

Volumn 6, Issue , 2013, Pages 23-38

  Ravn, Pernille ^a   Secher, Erik L ^b   Skram, Ulrik ^c   Therkildsen, Trine ^a   Christrup, Lona L ^a   Werner, Mads U ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Analgesia; Antihyperalgesia; Experimental pain; Opioid; Pain sensitivity; Randomized trial

Indexed keywords

BUPRENORPHINE; HYDROCORTISONE SODIUM SUCCINATE; MORPHINE; ONDANSETRON; PLACEBO; SODIUM CHLORIDE;

ADULT; ANALGESIA; ARTICLE; COLD PRESSOR TEST; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG PREFERENCE; ELECTROSTIMULATION; FEMALE; HEADACHE; HEARING IMPAIRMENT; HEAT INJURY; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; INFLAMMATORY PAIN; LOW DRUG DOSE; MALE; MECHANICAL STIMULATION; NAUSEA AND VOMITING; NOCICEPTION; NORMAL HUMAN; PAIN THRESHOLD; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; THERMAL STIMULATION; URINE RETENTION; VISUAL DISORDER; VOLUNTEER;

EID: 84874706459     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S36827     Document Type: Article

References (71)

1. Troster A, Ihmsen H, Singler B, Filitz J, Koppert W. Interaction of fentanyl and buprenorphine in an experimental model of pain and central sensitization in human volunteers. Clin J Pain. 2012;28(8): 705-711.
2. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104(3):570-587.
3. Koppert W. Opioid-induced hyperalgesia-pathophysiology and clinical relevance. Acute Pain. 2007;9:21-34.
4. Caroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med. 2004; 29(6):576-591.
5. Andresen T, Upton RN, Foster DJ, Christrup LL, Arendt-Nielsen L, Drewes AM. Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models. Basic Clin Pharmacol Toxicol. 2011;108(4):274-284.
6. Koppert W, Ihmsen H, Korber N, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005;118(1-2):15-22.
7. Angst MS, Phillips NG, Drover DR, et al. Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain. 2012;153(7): 1397-1409.
8. Abrishami A, Chan J, Chung F, Wong J. Preoperative pain sensitivity and its correlation with postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2011;114(2):445-457.
9. Werner MU, Mjobo HN, Nielsen PR, Rudin A. Prediction of postoperative pain: a systematic review of predictive experimental pain studies. Anesthesiology. 2010;112(6):1494-1502.
10. Clauw DJ, Williams D, Lauerman W, et al. Pain sensitivity as a correlate of clinical status in individuals with chronic low back pain. Spine (Phila Pa 1976). 1999;24(19):2035-2041.
11. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley JL 3rd. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain. 2009;143(3):172-178.
12. Arendt-Nielsen L, Andresen T, Malver LP, Oksche A, Mansikka H, Drewes AM. A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: a human experimental study. Clin J Pain. 2011;28(7):623-627.
13. Yarnitsky D, Arendt-Nielsen L, Bouhassira D, et al. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain. 2010;14(4):339.
14. Naert AL, Kehlet H, Kupers R. Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain. 2008;138(1): 163-171.
15. Pedersen JL, Kehlet H. Hyperalgesia in a human model of acute inflammatory pain: a methodological study. Pain. 1998;74(2-3): 139-151.
16. Werner MU, Duun P, Kehlet H. Prediction of postoperative pain by preoperative nociceptive responses to heat stimulation. Anesthesiology. 2004;100(1):115-119.
17. Ravn P, Frederiksen R, Skovsen AP, Christrup LL, Werner MU. Prediction of pain sensitivity in healthy volunteers. J Pain Res. 2012;5: 313-326.
18. Yassen A, Olofsen E, Romberg R, Sarton E, Danhof M, Dahan A. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology. 2006;104(6):1232-1242.
19. Mazoit JX, Butscher K, Samii K. Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites. Anesth Analg. 2007;105(1):70-78.
20. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2007;105(6):1615-1628.
21. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77.
22. Sullivan MJL, Bishop SR, Kivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524-532.
23. Borly L, Anderson IB, Bardram L, et al. Preoperative prediction model of outcome after cholecystectomy for symptomatic gallstones. Scand J Gastroenterol. 1999;34(11):1144-1152.
24. Jorgensen T, Teglbjerg JS, Wille-Jorgensen P, Bille T, Thorvaldsen P. Persisting pain after cholecystectomy. A prospective investigation. Scand J Gastroenterol. 1991;26(1):124-128.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
26. Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain. 2001; 90(3):261-269.
27. Gill DM, Reddon JR, Stefanyk WO, Hans HS. Finger tapping: effects of trials and sessions. Percept Mot Skills. 1986;62(2):675-678.
28. Zacny JP, Gutierrez S. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products. Pain Med. 2008;9(4):433-443.
29. Stener-Victorin E, Kowalski J, Lundeberg T. A new highly reliable instrument for the assessment of pre-and postoperative gynecological pain. Anesth Analg. 2002;95(1):151-157.
30. Moller KA, Johansson B, Berge OG. Assessing mechanical allodynia in the rat paw with a new electronic algometer. J Neurosci Methods. 1998;84(1-2):41-47.
31. Werner MU, Rotboll-Nielsen P, Ellehuus-Hilmersson C. Humidity affects the performance of von Frey monofilaments. Acta Anaesthesiol Scand. 2011;55(5):577-582.
32. Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain. 2009;144(1-2):16-19.
33. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138(1):22-28.
34. Eisenberg E, Midbari A, Haddad M, Pud D. Predicting the analgesic effect to oxycodone by "static" and "dynamic" quantitative sensory testing in healthy subjects. Pain. 2010;151(1):104-109.
35. Nielsen CS, Stubhaug A, Price DD, Vassend O, Czajkowski N, Harris JR. Individual differences in pain sensitivity: genetic and environmental contributions. Pain. 2008;136(1-2):21-29.
36. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism. 2006;55(4):515-524.
37. Koppert W, Angst M, Alsheimer M, et al. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain. 2003;106(1-2):91-99.
38. Pedersen JL, Kehlet H. Secondary hyperalgesia to heat stimuli after burn injury in man. Pain. 1998;76(3):377-384.
39. Weidner C, Schmelz M, Schmidt R, Hansson B, Handwerker HO, Torebjork HE. Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci. 1999; 19(22):10184-10190.
40. Brennum J, Arendt-Nielsen L, Horn A, Secher NH, Jensen TS. Quantitative sensory examination during epidural anaesthesia and analgesia in man: effects of morphine. Pain. 1993;52(1):75-83.
41. Lilleso J, Hammer NA, Pedersen JL, Kehlet H. Effect of peripheral morphine in a human model of acute inflammatory pain. Br J Anaesth. 2000;85(2):228-232.
42. Warncke T, Stubhaug A, Jorum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997;72(1-2):99-106.
43. Warncke T, Stubhaug A, Jorum E. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man. Pain. 2000;86(3):293-303.
44. Werner MU, Pedersen KL, Rowbotham MC, Dahl JB. Can healthy volunteers be phenotyped using cutaneous sensitization models? Forthcoming 2012.
45. Klauenberg S, Maier C, Assion HJ, et al. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain. 2008; 140(2):332-343.
46. Wang H, Fischer C, Chen G, Weinsheimer N, Gantz S, Schiltenwolf M. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing. Pain Physician. 2012;15(Suppl 3):ES135-ES143.
47. Werner MU, Perkins FM, Holte K, Pedersen JL, Kehlet H. Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med. 2001;26(4):322-328.
48. Brennum J, Dahl JB, Moiniche S, Arendt-Nielsen L. Quantitative sensory examination of epidural anaesthesia and analgesia in man: effects of pre-and post-traumatic morphine on hyperalgesia. Pain. 1994;59(2): 261-271.
49. Park R, Wallace MS, Schulteis G. Relative sensitivity to alfentanil and reliability of current perception threshold vs von Frey tactile stimulation and thermal sensory testing. J Peripher Nerv Syst. 2001;6(4): 232-240.
50. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91(1-2):177-187.
51. Cowan A. Buprenorphine: new pharmacological aspects. Int J Clin Pract Suppl. 2003;133:3-8.
52. Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol. 1996;20(6):369-378.
53. Belcheva MM, Barg J, McHale RJ, et al. Differential down-and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine. Mol Pharmacol. 1993;44(1):173-179.
54. Twycross RG. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv. 1988;7(1):29-53.
55. Sittl R. Transdermal buprenorphine in cancer pain and palliative care. Palliat Med. 2006;20(Suppl 1):s25-s30.
56. Andresen T, Staahl C, Oksche A, Mansikka H, Arendt-Nielsen L, Drewes AM. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain. Br J Pharmacol. 2011;164(3): 934-945.
57. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611-615.
58. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114(1-2):295-302.
59. Johannesson U, de Boussard CN, Brodda Jansen G, Bohm-Starke N. Evidence of diffuse noxious inhibitory controls (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia. Pain. 2007;130(1-2):31-39.
60. Olesen SS, Brock C, Krarup AL, et al. Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8(8):724-730.
61. Le Bars D, Willer JC, De Broucker T. Morphine blocks descending pain inhibitory controls in humans. Pain. 1992;48(1):13-20.
62. Willer JC, Le Bars D, De Broucker T. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur J Pharmacol. 1990;182(2):347-355.
63. Ram KC, Eisenberg E, Haddad M, Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain-new perspective of opioid-induced hyperalgesia. Pain. 2008;139(2):431-438.
64. Nielsen CS, Staud R, Price DD. Individual differences in pain sensitivity: measurement, causation, and consequences. J Pain. 2009;10(3):231-237.
65. Kindler LL, Valencia C, Fillingim RB, George SZ. Sex differences in experimental and clinical pain sensitivity for patients with shoulder pain. Eur J Pain. 2011;15(2):118-123.
66. Petersen-Felix S, Arendt-Nielsen L, Bak P, et al. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth. 1994;73(3): 326-330.
67. Stubhaug A, Romundstad L, Kaasa T, Breivik H. Methylprednisolone and ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds. Acta Anaesthesiol Scand. 2007;51(9): 1138-1146.
68. Greffrath W, Baumgartner U, Treede RD. Peripheral and central components of habituation of heat pain perception and evoked potentials in humans. Pain. 2007;132(3):301-311.
69. Granot M, Weissman-Fogel I, Crispel Y, et al. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: do conditioning stimulus painfulness, gender and personality variables matter? Pain. 2008;136(1-2):142-149.
70. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153(6):1193-1198.
71. Treister R, Eisenberg E, Gershon E, Haddad M, Pud D. Factors affecting-and relationships between-different modes of endogenous pain modulation in healthy volunteers. Eur J Pain. 2010;14(6): 608-614.